Phathom Pharmaceuticals, Inc. (PHAT) vs Replimune Group, Inc. (REPL)
Detailed comparison between Phathom Pharmaceuticals, Inc., Replimune Group, Inc..Total Return (%)
Phathom Pharmaceuticals, Inc. (PHAT)Replimune Group, Inc. (REPL)
Which stock do you think will perform better?
Phathom Pharmaceuticals, Inc.
PHAT
Replimune Group, Inc.
REPL
| Metric | Phathom Pharmaceuticals, Inc. (PHAT) | Replimune Group, Inc. (REPL) |
|---|---|---|
| Current Price | $2.29 | $7.77 |
| Change | -0.11 (-4.58%) | 0.61 (8.52%) |
| Market Cap | $0.16B | $0.60B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.57 | -2.89 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $19.71 | $17.00 |
| 52-Week Low | $2.21 | $4.92 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.18 | $-3.07 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| PHAT | -48.31% | -67.00% | -77.30% | -94.14% | -90.69% | -90.69% |
| REPL | 6.29% | -29.75% | 15.45% | -57.59% | -48.75% | -48.75% |